カテゴリ： QYResearch, 世界, 医療/バイオ

注射用メシル酸ガベキサートの世界市場2025年：40mg、80mg、120mg、160mg

■ 英語タイトル：Global Gabexate Mesylate for Injection Market Research Report 2025

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8767）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8767
■ 発行日：2025年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：86
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥417,600見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥626,400見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥835,200見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[注射用メシル酸ガベキサートの世界市場2025年：40mg、80mg、120mg、160mg]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料は注射用メシル酸ガベキサートのグローバル市場について調査・分析し、世界の注射用メシル酸ガベキサート市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（40mg、80mg、120mg、160mg）、用途別セグメント分析（病院薬局、小売薬局、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Medisan、Chongqing Pharscin Pharmaceutical Co., Ltd.、Chengdu Tiantai Mount Pharmaceutical、Shanxi Pude Pharmaceutical、Emeishan Tonghui Pharmaceuticalなどが含まれています。注射用メシル酸ガベキサートのグローバル市場は、2024年にXXX米ドル、2031年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。貿易戦争とロシア・ウクライナ戦争の影響は、注射用メシル酸ガベキサート市場規模を算出する際に考慮しました。

・注射用メシル酸ガベキサート市場の概要
- 製品の定義
- 注射用メシル酸ガベキサートの種類別セグメント
- 世界の注射用メシル酸ガベキサート市場規模：タイプ別分析（40mg、80mg、120mg、160mg）
- 注射用メシル酸ガベキサートの用途別セグメント
- 世界の注射用メシル酸ガベキサート市場規模：用途別分析（病院薬局、小売薬局、その他）
- 世界の注射用メシル酸ガベキサート市場規模予測（2020年-2031年）
- 注射用メシル酸ガベキサートの平均価格推移（2020年-2031年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- 注射用メシル酸ガベキサート市場の競争状況およびトレンド

・注射用メシル酸ガベキサートの地域別市場規模
- 北米の注射用メシル酸ガベキサート市場規模（2020年-2031年）
- 米国の注射用メシル酸ガベキサート市場規模（2020年-2031年）
- ヨーロッパの注射用メシル酸ガベキサート市場規模（2020年-2031年）
- アジア太平洋の注射用メシル酸ガベキサート市場規模（2020年-2031年）
- 中国の注射用メシル酸ガベキサート市場規模（2020年-2031年）
- 日本の注射用メシル酸ガベキサート市場規模（2020年-2031年）
- 韓国の注射用メシル酸ガベキサート市場規模（2020年-2031年）
- インドの注射用メシル酸ガベキサート市場規模（2020年-2031年）
- オーストラリアの注射用メシル酸ガベキサート市場規模（2020年-2031年）
- 中南米の注射用メシル酸ガベキサート市場規模（2020年-2031年）
- 中東・アフリカの注射用メシル酸ガベキサート市場規模（2020年-2031年）

・種類別セグメント：40mg、80mg、120mg、160mg
- 世界の注射用メシル酸ガベキサートのタイプ別販売量（2020年-2025年）
- 世界の注射用メシル酸ガベキサートのタイプ別売上（2020年-2025年）
- 世界の注射用メシル酸ガベキサートのタイプ別価格

・用途別セグメント：病院薬局、小売薬局、その他
- 世界の注射用メシル酸ガベキサートの用途別販売量（2020年-2025年）
- 世界の注射用メシル酸ガベキサートの用途別売上（2020年-2025年）
- 世界の注射用メシル酸ガベキサートの用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Medisan、Chongqing Pharscin Pharmaceutical Co., Ltd.、Chengdu Tiantai Mount Pharmaceutical、Shanxi Pude Pharmaceutical、Emeishan Tonghui Pharmaceutical

・産業チェーンと販売チャネルの分析
- 注射用メシル酸ガベキサート産業チェーン分析
- 注射用メシル酸ガベキサートの主要原材料
- 注射用メシル酸ガベキサートの販売チャネル
- 注射用メシル酸ガベキサートのディストリビューター
- 注射用メシル酸ガベキサートの主要顧客

・注射用メシル酸ガベキサート市場ダイナミクス
- 注射用メシル酸ガベキサートの業界動向
- 注射用メシル酸ガベキサート市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Highlights
The global Gabexate Mesylate for Injection market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of % during the forecast period 2025-2031. The influence of trade war and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Gabexate Mesylate for Injection is estimated to increase from $ million in 2023 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Gabexate Mesylate for Injection is estimated to increase from $ million in 2023 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The key global manufacturers of Gabexate Mesylate for Injection include Medisan, Chongqing Pharscin Pharmaceutical Co., Ltd., Chengdu Tiantai Mount Pharmaceutical, Shanxi Pude Pharmaceutical and Emeishan Tonghui Pharmaceutical, etc. in 2024, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Gabexate Mesylate for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gabexate Mesylate for Injection.
The Gabexate Mesylate for Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gabexate Mesylate for Injection market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gabexate Mesylate for Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Medisan
Chongqing Pharscin Pharmaceutical Co., Ltd.
Chengdu Tiantai Mount Pharmaceutical
Shanxi Pude Pharmaceutical
Emeishan Tonghui Pharmaceutical
Segment by Type
40mg
80mg
120mg
160mg
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Gabexate Mesylate for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Gabexate Mesylate for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Gabexate Mesylate for Injection Market Overview
1.1 Product Overview and Scope of Gabexate Mesylate for Injection
1.2 Gabexate Mesylate for Injection Segment by Type
1.2.1 Global Gabexate Mesylate for Injection Market Value Comparison by Type (2025-2031)
1.2.2 40mg
1.2.3 80mg
1.2.4 120mg
1.2.5 160mg
1.3 Gabexate Mesylate for Injection Segment by Application
1.3.1 Global Gabexate Mesylate for Injection Market Value by Application: (2025-2031)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Global Gabexate Mesylate for Injection Market Size Estimates and Forecasts
1.4.1 Global Gabexate Mesylate for Injection Revenue 2020-2031
1.4.2 Global Gabexate Mesylate for Injection Sales 2020-2031
1.4.3 Global Gabexate Mesylate for Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Gabexate Mesylate for Injection Market Competition by Manufacturers
2.1 Global Gabexate Mesylate for Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Gabexate Mesylate for Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Gabexate Mesylate for Injection Average Price by Manufacturers (2020-2025)
2.4 Global Gabexate Mesylate for Injection Industry Ranking 2023 VS 2024 VS 2025
2.5 Global Key Manufacturers of Gabexate Mesylate for Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gabexate Mesylate for Injection, Product Type & Application
2.7 Gabexate Mesylate for Injection Market Competitive Situation and Trends
2.7.1 Gabexate Mesylate for Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Gabexate Mesylate for Injection Players Market Share by Revenue
2.7.3 Global Gabexate Mesylate for Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Gabexate Mesylate for Injection Retrospective Market Scenario by Region
3.1 Global Gabexate Mesylate for Injection Market Size by Region: 2020 Versus 2024 Versus 2025
3.2 Global Gabexate Mesylate for Injection Global Gabexate Mesylate for Injection Sales by Region: 2020-2031
3.2.1 Global Gabexate Mesylate for Injection Sales by Region: 2020-2025
3.2.2 Global Gabexate Mesylate for Injection Sales by Region: 2026-2031
3.3 Global Gabexate Mesylate for Injection Global Gabexate Mesylate for Injection Revenue by Region: 2020-2031
3.3.1 Global Gabexate Mesylate for Injection Revenue by Region: 2020-2025
3.3.2 Global Gabexate Mesylate for Injection Revenue by Region: 2026-2031
3.4 North America Gabexate Mesylate for Injection Market Facts & Figures by Country
3.4.1 North America Gabexate Mesylate for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Gabexate Mesylate for Injection Sales by Country (2020-2031)
3.4.3 North America Gabexate Mesylate for Injection Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Gabexate Mesylate for Injection Market Facts & Figures by Country
3.5.1 Europe Gabexate Mesylate for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Gabexate Mesylate for Injection Sales by Country (2020-2031)
3.5.3 Europe Gabexate Mesylate for Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gabexate Mesylate for Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Gabexate Mesylate for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Gabexate Mesylate for Injection Sales by Country (2020-2031)
3.6.3 Asia Pacific Gabexate Mesylate for Injection Revenue by Country (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Gabexate Mesylate for Injection Market Facts & Figures by Country
3.7.1 Latin America Gabexate Mesylate for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Gabexate Mesylate for Injection Sales by Country (2020-2031)
3.7.3 Latin America Gabexate Mesylate for Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Gabexate Mesylate for Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Gabexate Mesylate for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Gabexate Mesylate for Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Gabexate Mesylate for Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Gabexate Mesylate for Injection Sales by Type (2020-2031)
4.1.1 Global Gabexate Mesylate for Injection Sales by Type (2020-2025)
4.1.2 Global Gabexate Mesylate for Injection Sales by Type (2026-2031)
4.1.3 Global Gabexate Mesylate for Injection Sales Market Share by Type (2020-2031)
4.2 Global Gabexate Mesylate for Injection Revenue by Type (2020-2031)
4.2.1 Global Gabexate Mesylate for Injection Revenue by Type (2020-2025)
4.2.2 Global Gabexate Mesylate for Injection Revenue by Type (2026-2031)
4.2.3 Global Gabexate Mesylate for Injection Revenue Market Share by Type (2020-2031)
4.3 Global Gabexate Mesylate for Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Gabexate Mesylate for Injection Sales by Application (2020-2031)
5.1.1 Global Gabexate Mesylate for Injection Sales by Application (2020-2025)
5.1.2 Global Gabexate Mesylate for Injection Sales by Application (2026-2031)
5.1.3 Global Gabexate Mesylate for Injection Sales Market Share by Application (2020-2031)
5.2 Global Gabexate Mesylate for Injection Revenue by Application (2020-2031)
5.2.1 Global Gabexate Mesylate for Injection Revenue by Application (2020-2025)
5.2.2 Global Gabexate Mesylate for Injection Revenue by Application (2026-2031)
5.2.3 Global Gabexate Mesylate for Injection Revenue Market Share by Application (2020-2031)
5.3 Global Gabexate Mesylate for Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Medisan
6.1.1 Medisan Corporation Information
6.1.2 Medisan Description and Business Overview
6.1.3 Medisan Gabexate Mesylate for Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Medisan Gabexate Mesylate for Injection Product Portfolio
6.1.5 Medisan Recent Developments/Updates
6.2 Chongqing Pharscin Pharmaceutical Co., Ltd.
6.2.1 Chongqing Pharscin Pharmaceutical Co., Ltd. Corporation Information
6.2.2 Chongqing Pharscin Pharmaceutical Co., Ltd. Description and Business Overview
6.2.3 Chongqing Pharscin Pharmaceutical Co., Ltd. Gabexate Mesylate for Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Chongqing Pharscin Pharmaceutical Co., Ltd. Gabexate Mesylate for Injection Product Portfolio
6.2.5 Chongqing Pharscin Pharmaceutical Co., Ltd. Recent Developments/Updates
6.3 Chengdu Tiantai Mount Pharmaceutical
6.3.1 Chengdu Tiantai Mount Pharmaceutical Corporation Information
6.3.2 Chengdu Tiantai Mount Pharmaceutical Description and Business Overview
6.3.3 Chengdu Tiantai Mount Pharmaceutical Gabexate Mesylate for Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Chengdu Tiantai Mount Pharmaceutical Gabexate Mesylate for Injection Product Portfolio
6.3.5 Chengdu Tiantai Mount Pharmaceutical Recent Developments/Updates
6.4 Shanxi Pude Pharmaceutical
6.4.1 Shanxi Pude Pharmaceutical Corporation Information
6.4.2 Shanxi Pude Pharmaceutical Description and Business Overview
6.4.3 Shanxi Pude Pharmaceutical Gabexate Mesylate for Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Shanxi Pude Pharmaceutical Gabexate Mesylate for Injection Product Portfolio
6.4.5 Shanxi Pude Pharmaceutical Recent Developments/Updates
6.5 Emeishan Tonghui Pharmaceutical
6.5.1 Emeishan Tonghui Pharmaceutical Corporation Information
6.5.2 Emeishan Tonghui Pharmaceutical Description and Business Overview
6.5.3 Emeishan Tonghui Pharmaceutical Gabexate Mesylate for Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Emeishan Tonghui Pharmaceutical Gabexate Mesylate for Injection Product Portfolio
6.5.5 Emeishan Tonghui Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Gabexate Mesylate for Injection Industry Chain Analysis
7.2 Gabexate Mesylate for Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gabexate Mesylate for Injection Production Mode & Process
7.4 Gabexate Mesylate for Injection Sales and Marketing
7.4.1 Gabexate Mesylate for Injection Sales Channels
7.4.2 Gabexate Mesylate for Injection Distributors
7.5 Gabexate Mesylate for Injection Customers
8 Gabexate Mesylate for Injection Market Dynamics
8.1 Gabexate Mesylate for Injection Industry Trends
8.2 Gabexate Mesylate for Injection Market Drivers
8.3 Gabexate Mesylate for Injection Market Challenges
8.4 Gabexate Mesylate for Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Gabexate Mesylate for Injection Market Value Comparison by Type (2025-2031) & (US$ Million)
Table 2. Global Gabexate Mesylate for Injection Market Value Comparison by Application (2025-2031) & (US$ Million)
Table 3. Global Gabexate Mesylate for Injection Market Competitive Situation by Manufacturers in 2024
Table 4. Global Gabexate Mesylate for Injection Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Gabexate Mesylate for Injection Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Gabexate Mesylate for Injection Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Gabexate Mesylate for Injection Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Gabexate Mesylate for Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Gabexate Mesylate for Injection, Industry Ranking, 2023 VS 2024 VS 2025
Table 10. Global Key Manufacturers of Gabexate Mesylate for Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Gabexate Mesylate for Injection, Product Type & Application
Table 12. Global Key Manufacturers of Gabexate Mesylate for Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Gabexate Mesylate for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gabexate Mesylate for Injection as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Gabexate Mesylate for Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Gabexate Mesylate for Injection Sales by Region (2020-2025) & (K Units)
Table 18. Global Gabexate Mesylate for Injection Sales Market Share by Region (2020-2025)
Table 19. Global Gabexate Mesylate for Injection Sales by Region (2026-2031) & (K Units)
Table 20. Global Gabexate Mesylate for Injection Sales Market Share by Region (2026-2031)
Table 21. Global Gabexate Mesylate for Injection Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Gabexate Mesylate for Injection Revenue Market Share by Region (2020-2025)
Table 23. Global Gabexate Mesylate for Injection Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Gabexate Mesylate for Injection Revenue Market Share by Region (2026-2031)
Table 25. North America Gabexate Mesylate for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Gabexate Mesylate for Injection Sales by Country (2020-2025) & (K Units)
Table 27. North America Gabexate Mesylate for Injection Sales by Country (2026-2031) & (K Units)
Table 28. North America Gabexate Mesylate for Injection Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Gabexate Mesylate for Injection Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Gabexate Mesylate for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Gabexate Mesylate for Injection Sales by Country (2020-2025) & (K Units)
Table 32. Europe Gabexate Mesylate for Injection Sales by Country (2026-2031) & (K Units)
Table 33. Europe Gabexate Mesylate for Injection Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Gabexate Mesylate for Injection Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Gabexate Mesylate for Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Gabexate Mesylate for Injection Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Gabexate Mesylate for Injection Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Gabexate Mesylate for Injection Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Gabexate Mesylate for Injection Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Gabexate Mesylate for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Gabexate Mesylate for Injection Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Gabexate Mesylate for Injection Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Gabexate Mesylate for Injection Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Gabexate Mesylate for Injection Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Gabexate Mesylate for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East & Africa Gabexate Mesylate for Injection Sales by Country (2020-2025) & (K Units)
Table 47. Middle East & Africa Gabexate Mesylate for Injection Sales by Country (2026-2031) & (K Units)
Table 48. Middle East & Africa Gabexate Mesylate for Injection Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East & Africa Gabexate Mesylate for Injection Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Gabexate Mesylate for Injection Sales (K Units) by Type (2020-2025)
Table 51. Global Gabexate Mesylate for Injection Sales (K Units) by Type (2026-2031)
Table 52. Global Gabexate Mesylate for Injection Sales Market Share by Type (2020-2025)
Table 53. Global Gabexate Mesylate for Injection Sales Market Share by Type (2026-2031)
Table 54. Global Gabexate Mesylate for Injection Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Gabexate Mesylate for Injection Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Gabexate Mesylate for Injection Revenue Market Share by Type (2020-2025)
Table 57. Global Gabexate Mesylate for Injection Revenue Market Share by Type (2026-2031)
Table 58. Global Gabexate Mesylate for Injection Price (US$/Unit) by Type (2020-2025)
Table 59. Global Gabexate Mesylate for Injection Price (US$/Unit) by Type (2026-2031)
Table 60. Global Gabexate Mesylate for Injection Sales (K Units) by Application (2020-2025)
Table 61. Global Gabexate Mesylate for Injection Sales (K Units) by Application (2026-2031)
Table 62. Global Gabexate Mesylate for Injection Sales Market Share by Application (2020-2025)
Table 63. Global Gabexate Mesylate for Injection Sales Market Share by Application (2026-2031)
Table 64. Global Gabexate Mesylate for Injection Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Gabexate Mesylate for Injection Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Gabexate Mesylate for Injection Revenue Market Share by Application (2020-2025)
Table 67. Global Gabexate Mesylate for Injection Revenue Market Share by Application (2026-2031)
Table 68. Global Gabexate Mesylate for Injection Price (US$/Unit) by Application (2020-2025)
Table 69. Global Gabexate Mesylate for Injection Price (US$/Unit) by Application (2026-2031)
Table 70. Medisan Corporation Information
Table 71. Medisan Description and Business Overview
Table 72. Medisan Gabexate Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Medisan Gabexate Mesylate for Injection Product
Table 74. Medisan Recent Developments/Updates
Table 75. Chongqing Pharscin Pharmaceutical Co., Ltd. Corporation Information
Table 76. Chongqing Pharscin Pharmaceutical Co., Ltd. Description and Business Overview
Table 77. Chongqing Pharscin Pharmaceutical Co., Ltd. Gabexate Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Chongqing Pharscin Pharmaceutical Co., Ltd. Gabexate Mesylate for Injection Product
Table 79. Chongqing Pharscin Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 80. Chengdu Tiantai Mount Pharmaceutical Corporation Information
Table 81. Chengdu Tiantai Mount Pharmaceutical Description and Business Overview
Table 82. Chengdu Tiantai Mount Pharmaceutical Gabexate Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Chengdu Tiantai Mount Pharmaceutical Gabexate Mesylate for Injection Product
Table 84. Chengdu Tiantai Mount Pharmaceutical Recent Developments/Updates
Table 85. Shanxi Pude Pharmaceutical Corporation Information
Table 86. Shanxi Pude Pharmaceutical Description and Business Overview
Table 87. Shanxi Pude Pharmaceutical Gabexate Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Shanxi Pude Pharmaceutical Gabexate Mesylate for Injection Product
Table 89. Shanxi Pude Pharmaceutical Recent Developments/Updates
Table 90. Emeishan Tonghui Pharmaceutical Corporation Information
Table 91. Emeishan Tonghui Pharmaceutical Description and Business Overview
Table 92. Emeishan Tonghui Pharmaceutical Gabexate Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Emeishan Tonghui Pharmaceutical Gabexate Mesylate for Injection Product
Table 94. Emeishan Tonghui Pharmaceutical Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Gabexate Mesylate for Injection Distributors List
Table 98. Gabexate Mesylate for Injection Customers List
Table 99. Gabexate Mesylate for Injection Market Trends
Table 100. Gabexate Mesylate for Injection Market Drivers
Table 101. Gabexate Mesylate for Injection Market Challenges
Table 102. Gabexate Mesylate for Injection Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Gabexate Mesylate for Injection
Figure 2. Global Gabexate Mesylate for Injection Market Value Comparison by Type (2025-2031) & (US$ Million)
Figure 3. Global Gabexate Mesylate for Injection Market Share by Type in 2024 & 2031
Figure 4. 40mg Product Picture
Figure 5. 80mg Product Picture
Figure 6. 120mg Product Picture
Figure 7. 160mg Product Picture
Figure 8. Global Gabexate Mesylate for Injection Market Value Comparison by Application (2025-2031) & (US$ Million)
Figure 9. Global Gabexate Mesylate for Injection Market Share by Application in 2024 & 2031
Figure 10. Hospital Pharmacy
Figure 11. Retail Pharmacy
Figure 12. Others
Figure 13. Global Gabexate Mesylate for Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Gabexate Mesylate for Injection Market Size (2020-2031) & (US$ Million)
Figure 15. Global Gabexate Mesylate for Injection Sales (2020-2031) & (K Units)
Figure 16. Global Gabexate Mesylate for Injection Average Price (US$/Unit) & (2020-2031)
Figure 17. Gabexate Mesylate for Injection Report Years Considered
Figure 18. Gabexate Mesylate for Injection Sales Share by Manufacturers in 2024
Figure 19. Global Gabexate Mesylate for Injection Revenue Share by Manufacturers in 2024
Figure 20. The Global 5 and 10 Largest Gabexate Mesylate for Injection Players: Market Share by Revenue in 2024
Figure 21. Gabexate Mesylate for Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2020 VS 2024
Figure 22. Global Gabexate Mesylate for Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Gabexate Mesylate for Injection Sales Market Share by Country (2020-2031)
Figure 24. North America Gabexate Mesylate for Injection Revenue Market Share by Country (2020-2031)
Figure 25. U.S. Gabexate Mesylate for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Gabexate Mesylate for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Gabexate Mesylate for Injection Sales Market Share by Country (2020-2031)
Figure 28. Europe Gabexate Mesylate for Injection Revenue Market Share by Country (2020-2031)
Figure 29. Germany Gabexate Mesylate for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Gabexate Mesylate for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Gabexate Mesylate for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Gabexate Mesylate for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Gabexate Mesylate for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Gabexate Mesylate for Injection Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Gabexate Mesylate for Injection Revenue Market Share by Region (2020-2031)
Figure 36. China Gabexate Mesylate for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Gabexate Mesylate for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Gabexate Mesylate for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Gabexate Mesylate for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Gabexate Mesylate for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Taiwan Gabexate Mesylate for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Indonesia Gabexate Mesylate for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Thailand Gabexate Mesylate for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Malaysia Gabexate Mesylate for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Philippines Gabexate Mesylate for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Latin America Gabexate Mesylate for Injection Sales Market Share by Country (2020-2031)
Figure 47. Latin America Gabexate Mesylate for Injection Revenue Market Share by Country (2020-2031)
Figure 48. Mexico Gabexate Mesylate for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Brazil Gabexate Mesylate for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Argentina Gabexate Mesylate for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Middle East & Africa Gabexate Mesylate for Injection Sales Market Share by Country (2020-2031)
Figure 52. Middle East & Africa Gabexate Mesylate for Injection Revenue Market Share by Country (2020-2031)
Figure 53. Turkey Gabexate Mesylate for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Saudi Arabia Gabexate Mesylate for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. U.A.E Gabexate Mesylate for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Global Sales Market Share of Gabexate Mesylate for Injection by Type (2020-2031)
Figure 57. Global Revenue Market Share of Gabexate Mesylate for Injection by Type (2020-2031)
Figure 58. Global Gabexate Mesylate for Injection Price (US$/Unit) by Type (2020-2031)
Figure 59. Global Sales Market Share of Gabexate Mesylate for Injection by Application (2020-2031)
Figure 60. Global Revenue Market Share of Gabexate Mesylate for Injection by Application (2020-2031)
Figure 61. Global Gabexate Mesylate for Injection Price (US$/Unit) by Application (2020-2031)
Figure 62. Gabexate Mesylate for Injection Value Chain
Figure 63. Gabexate Mesylate for Injection Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

※参考情報

注射用メシル酸ガベキサート（Gabexate Mesylate for Injection）は、主に抗凝固薬として用いられる医薬品で、その特性や用途について深く理解することは、医療現場におけるその効用を最大限に引き出すために重要です。以下に、その概念や特徴、用途などについて詳しく述べます。

まず、メシル酸ガベキサートについての基本的な定義を確認します。この薬剤は、プロテアーゼ阻害剤として分類され、血液中の凝固因子の活性を抑制することにより、血液の凝固を防ぎます。この特性から、主に手術後の血栓症予防や、急性膵炎や肝疾患に伴う合併症の管理に使用されることが多いです。

続いて、この薬剤の特徴に触れます。ガベキサートは、体内での吸収が速く、迅速な効果を発揮することが特徴です。これにより、緊急の患者に対して迅速に処置を行う際に非常に有用です。また、副作用が比較的少ないことも、医療現場において選ばれる理由の一つです。一般的には、出血症状やアレルギー反応が見られることがありますが、これらは比較的稀です。

さらに、ガベキサートは多くの種類の血栓症の予防・治療に適応されており、特に静脈血栓塞栓症や肺塞栓症の予防として効果的です。急性膵炎においては、膵液の分泌を抑制し、炎症を軽減することが期待されます。また、肝疾患においても、血流動態の改善に寄与し、合併症のリスクを軽減する効果が見込まれます。

この薬剤の用途には、一般的な手術後の血液凝固予防だけでなく、特定の疾患に関連する様々な状況が含まれます。特に、急性膵炎患者においては、内因性の膵酵素活性を抑えることで、症状の悪化を防ぐ働きが注目されています。また、血液透析や心臓手術においても、その特性を活かした使用が行われています。

関連技術については、ガベキサートの適応を広げるための研究が進行中です。例えば、より効果的な投与方法や、他の抗凝固薬との併用に関する研究も行われています。また、ガベキサートの作用機序や、他の薬剤との相互作用についての理解が進むことで、より安全で効果的な治療法が開発されることが期待されています。

ガベキサートは、投与ルートとして主に静脈内注射が用いられますが、患者の状態に応じて投与量や投与間隔が調整されます。これにより、患者ごとの個別化医療が実現されることになります。医療従事者は、患者の状態を適切に把握し、治療計画を立てることで、最良の結果を導き出す必要があります。

さらに重要な点として、メシル酸ガベキサートの使用には、患者の基本的な健康状態やアレルギー歴を考慮する必要があります。薬剤の効果を最大限に引き出すためには、これらの情報を基にした慎重な判断が求められます。また、定期的な血液検査やモニタリングを実施し、出血リスクやその他の副作用を監視することも重要です。

最後に、未来の展望として、メシル酸ガベキサートは新しい治療法としての可能性が期待されています。老化に伴う血栓症の発症が増加する中、メシル酸ガベキサートのような抗凝固薬は、ますます重要な役割を果たすと考えられています。生物学的な研究や新しい製剤の開発が進む中で、ガベキサートの活用の幅が広がることが期待されます。

以上のように、注射用メシル酸ガベキサートは、血液の凝固を抑制することで多様な用途を持った薬剤です。その迅速な効果、副作用の少なさ、そしてさまざまな適応状況は、医療現場において高く評価されています。今後の研究により、一層の利用拡大が期待されるこの薬剤を通じて、患者さんの治療がより効果的に行われることが望まれます。


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • エノキサパリンナトリウムAPI&製剤のグローバル市場2023：20mg/0.2mL、40mg/0.4mL、60mg/0.6mL、80mg/0.8mL、100mg/1mL、120mg/0.8mL、150mg/1mL、300mg/3mL
  • ドセタキセル注射液の世界市場2025年：10mg/ml、20mg/ml、40mg/ml、その他
  • ランレオチドの世界市場2025年：60mg、90mg、120mg
  • ソマチュリン医薬品の世界市場2025年：60mg、90mg、120mg
  • ランレオチド薬の世界市場2025年：60mg、90mg、120mg
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8767 )"注射用メシル酸ガベキサートの世界市場2025年：40mg、80mg、120mg、160mg" (英文：Global Gabexate Mesylate for Injection Market Research Report 2025)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。